Kanamaru M, Homma I. Compensatory airway dilation and additive ventilatory augmentation mediated by dorsomedial medullary 5-hydroxytryptamine 2 receptor activity and hypercapnia. Am J Physiol Regul Integr Comp Physiol 293: R854-R860, 2007. First published May 30, 2007; doi:10.1152 doi:10. /ajpregu.00829.2006 receptor activity in the hypoglossal nucleus and hypercapnia is associated with airway dilation. 5-HT neurons in the medullary raphe and hypercapnia are responsible for tidal volume change. In this study, the effects of 5-HT2 receptors in the dorsomedial medulla oblongata (DMM), which receives projections from the medullary raphe, and hypercapnia on airway resistance and respiratory variables were studied in mice while monitoring 5-HT release in the DMM. A microdialysis probe was inserted into the DMM of anesthetized adult mice. Each mouse was placed in a double-chamber plethysmograph. After recovery from anesthesia, the mice were exposed to stepwise increases in CO 2 inhalation (5%, 7%, and 9% CO2 in O2) at 8-min intervals with a selective serotonin reuptake inhibitor, fluoxetine, or fluoxetine plus a 5-HT2 receptor antagonist, LY-53857 in the DMM. In response to fluoxetine plus LY-53857 coperfusion, specific airway resistance was increased, and tidal volume and minute ventilation were decreased. CO 2 inhalation with fluoxetine plus LY-53857 coperfusion in the DMM largely decreased airway resistance and additively increased minute ventilation. Thus, 5-HT2 receptor activity in the DMM increases basal levels of airway dilation and ventilatory volume, dependent on central inspiratory activity and the volume threshold of the inspiratory off-switch mechanism. Hypercapnia with low 5-HT2 receptor activity in the DMM largely recovers airway dilation and additively increases ventilatory volume. Interaction between 5-HT2 receptor activity in the DMM and CO 2 drive may elicit a cycle of hyperventilation with airway dilation and hypoventilation with airway narrowing. serotonin; hypoglossal nucleus; airway resistance; solitary tract nucleus; respiration IN THE HYPOGLOSSAL NUCLEUS (nXII), perfusion with serotonin (5-HT) increases sleep-associated genioglossus muscle activity to levels of normal awakeness in rats (19). Hypoglossal motoneurons in cats and hypoglossal nerve activity in rats are stimulated via 5-HT2 receptor activation (7, 23). A selective serotonin reuptake inhibitor (SSRI), paroxetine, increases genioglossal electromyographic activity in normal subjects (41). Some SSRIs decrease the apnea index during non-rapid eye movement sleep in patients with obstructive sleep apnea (OSA) (12, 21). Thus, 5-HT2 receptor activity in the nXII excites the hypoglossal nerve and activates the genioglossus muscle.
IN THE HYPOGLOSSAL NUCLEUS (nXII), perfusion with serotonin (5-HT) increases sleep-associated genioglossus muscle activity to levels of normal awakeness in rats (19) . Hypoglossal motoneurons in cats and hypoglossal nerve activity in rats are stimulated via 5-HT2 receptor activation (7, 23) . A selective serotonin reuptake inhibitor (SSRI), paroxetine, increases genioglossal electromyographic activity in normal subjects (41) . Some SSRIs decrease the apnea index during non-rapid eye movement sleep in patients with obstructive sleep apnea (OSA) (12, 21) . Thus, 5-HT2 receptor activity in the nXII excites the hypoglossal nerve and activates the genioglossus muscle.
Hypercapnia decreases upper airway resistance, which is linear with respect to increasing CO 2 in dogs and humans (30, 46) . CO 2 rebreathing increases inspiratory genioglossal electromyographic responses in goats (31) . Hypercapnia increases the discharge rate of genioglossus muscle motor units and genioglossus muscle activity in rats (20) . These results suggest that hypercapnia induces airway dilation by increasing genioglossus muscle activation.
Most of the serotonergic afferents to the nXII originate in the raphe pallidus and obscurus nuclei (26) , from which serotonergic neurons also project to the solitary tract nucleus (nTS) (43) . In the nTS, some neurons activated by local 5-HT2 receptors enhance the bradycardiac component of the baroreflex (34, 38) . However, the effects of 5-HT2 receptors in the nTS on respiration, are not well characterized.
Some nTS neurons in rats and mice, comprising the dorsal respiratory group in the central respiratory control network, express c-Fos in response to hypercapnia (18, 42) . However, details of hypercapnic respiratory responses mediated via nTS neurons are unclear.
There are various reports regarding central chemoreception, indicating that the ventrolateral medulla is a chemosensitive area (24) , in which ATP is a chemical mediator (10) , and glutamatergic neurons in the retrotrapezoid nucleus are central chemoreceptors (11) . In addition, the majority of medullary raphe serotonergic neurons, some of which project to the nXII and the nTS, are stimulated by CO 2 and pH (35) . In the present study, we examined how 5-HT2 receptors in the dorsomedial medulla oblongata (DMM), including the nXII and the nTS, interact with hypercapnia to control the airway and respiration in mice using local perfusion of a SSRI, fluoxetine, and a 5-HT2 receptor antagonist, LY-53857.
METHODS
General. Experiments were performed with male C57BL/6N mice (CLEA Japan, Tokyo Japan) [10.8 Ϯ 0.8 wk of age, 25.0 Ϯ 0.6 g (SE)]. Mice were housed on a 12:12-h light-dark cycle with lights on at 0800 AM and had free access to food and water except during the experimental period. Experiments were approved by the Showa University Animal Experiments Committee. Each mouse was anesthetized with pentobarbital sodium (0.5 mg/0.1 ml saline/10 g body wt ip). The onset of a surgical level of anesthesia was determined by a loss of postural reflex on a slope and ease of head mounting on a stereotaxic instrument. Rectal temperature was maintained at 37°C with a heating blanket. The head region was cleaned with isodine antiseptic and locally anesthetized by 2% xylocaine injection (6, 44) . The medulla oblongata was exposed dorsally via a small hole made by drilling the end of the occipital bone. A microdialysis probe (CMA/7; 1 mm membrane length; 0.24 mm diameter; 6000 Da cutoff; Carnegie Medicin, Stockholm Sweden) was inserted to a depth of 1 mm from the dorsal brain surface 0.45 mm lateral to the midline and 0.8 mm rostral to the obex. The cranial bone was cleaned with 10% H 2O2, and the inserted probe was fixed to the cranial bone with dental cement. The skin incision was closed with sterilized 5-0 silk sutures. Each mouse was placed in a double-chamber plethysmograph and was given ϳ3.5 h to recover from anesthesia and become acclimatized to the chamber. The head and body chambers were provided with two continuous airflows of 150 ml/min with a vacuum pump. Dialysate (artificial cerebrospinal fluid [121.1 mM NaCl, 5 mM KCl, 24 mM NaHCO 3, and 1.5 mM CaCl2 adjusted to pH 7.4 with 95% O2 and 5% CO2]) was collected at a rate of 1.2 l/min every 25 min into a vial containing 10 l 0.02 M acetic acid.
5-HT release was analyzed with an HPLC system equipped with an electrochemical detector (BMA-300; EiCOM, Kyoto, Japan) and an EICOMPAK column (CA-5ODS, 2.1 mm ID ϫ 150 mm; EiCOM). The mobile phase was composed of 0.1 M sodium phosphate buffer (pH 6.0) containing 5% methanol, 50 mg/l EDTA⅐2Na, and 100 mg/l sodium pentanesulfonate. The flow rate was 0.23 ml/min. The column temperature was maintained at 25°C. 5-HT was oxidized at 400 mV on a graphite electrode relative to an Ag-AgCl reference electrode. Thirty-five microliters of each 40-l sample was injected into the HPLC apparatus with the use of an autosampler (NANOSPACE SI-2; Shiseido, Tokyo, Japan).
Chromatographs were recorded and analyzed with a PowerChrom system (EPC-300; EiCOM). The detection limit of the HPLC system for 5-HT was 3.4 fmol/35 l (signal-to-noise ratio ϭ 3).
Two concomitant curves for respiratory flow from the head and body chambers were obtained with pneumotachographs (TV-241T; Nihon Kohden, Tokyo, Japan), and pressure transducers (TR-602T; Nihon Kohden) recorded at a 10-kHz sampling rate and were later analyzed with PowerLab (ADI Instruments, NSW, Australia) (15, 47) . Ventilatory volume was calculated from the respiratory flow curve for the head chamber calibrated with injection of 0.5 ml air. Specific airway resistance (sR aw) was calculated with a time delay between head and body chamber flows (33) . Rectal temperature was maintained at 37°C by a heating lamp throughout the entire experimental period. Probe placement sites were verified in 50-m-thick coronal sections.
CO 2 inhalation. 5-HT release in the DMM was increased by fluoxetine (Sigma-Aldrich, St. Louis, MO) perfusion or 10 Ϫ5 M fluoxetine plus 10 Ϫ5 M LY-53857 (Sigma-Aldrich) coperfusion in the DMM for 75 min. Airway resistance was increased concomitantly by 10 Ϫ5 M fluoxetine and LY-53857 coperfusion. After confirming the increase in 5-HT release with 10 Ϫ5 M fluoxetine or the increase in sRaw with 10 Ϫ5 M LY-53857 or both, all mice were exposed to 100% O2 for 25 min and then to stepwise CO2 inhalation (5%, 7%, and 9% CO2 in O2) at intervals of 8 min. The flow rate of each gas to the inlet of the head chamber was 2 l/min with overflow.
Data analysis. Respiratory variables were analyzed for 5 s at 3.5 and 7.5 min after each gas exposure and were averaged over two measurements. Changes in sR aw relative to inspired CO2 concentration were expressed as means Ϯ SE of percentages of the minimum value of sR aw (% of minimum sRaw) and evaluated with Dunnett's test. The difference in sRaw during 100% O2 inhalation between fluoxetine perfusion and fluoxetine plus LY-53857 coperfusion was evaluated by Student's t-test. Tidal volume (V T)-inspiratory time (TI) curves were evaluated by inverse regression curve analysis, slope changes, and shifts (3) were evaluated by covariance analysis. Other data were expressed as means Ϯ SE and evaluated by two-way ANOVA (SPSS Japan, Tokyo, Japan). P Ͻ 0.05 was considered statistically significant.
RESULTS
Body temperature was maintained at ϳ37°C; there was no difference between the fluoxetine-perfused group and the fluoxetine plus LY-53857-coperfused group (Fig. 1) . After recovery from anesthesia, respiratory curves showed irregular waves elicited by movement and apnea in addition to regular waves. In those cases, respiratory variables were analyzed for 5 s during periods of regular respiratory waves just before the occurrence of artifacts (Fig. 2) .
5-HT release in the DMM during CO 2 inhalation. Under the baseline condition during 100% O 2 inhalation for 25 min, 5-HT release was 11.0 Ϯ 3.2 fmol/35 l with fluoxetine perfusion (n ϭ 3) and 12.0 Ϯ 1.4 fmol/35 l with fluoxetine plus LY-53857 coperfusion (n ϭ 5). 5-HT release elicited by inhalation of 5%, 7%, and 9% CO 2 in O 2 at 8-min intervals was 26.8 Ϯ 6.2 fmol/35 l with fluoxetine perfusion (n ϭ 3) and 30.7 Ϯ 6.0 fmol/35 l with fluoxetine plus LY-53857 coperfusion (n ϭ 5). 5-HT release was increased up to 2.4-fold that of basal release during fluoxetine perfusion and 2.6-fold that of basal release during fluoxetine plus LY-53857 coperfusion. The increase in 5-HT release in the DMM did not differ significantly between the two groups (Fig. 3A) .
The sites of microdialysis probe placement in the DMM were in the nXII, the nTS, and the dorsal motor nucleus of the vagus. The distribution was similar between the fluoxetineperfused group (Fig. 3B ) and the fluoxetine plus LY-53857-coperfused group (Fig. 3C) .
Effects of 5-HT2 receptors in the DMM on airway and respiratory responses during CO 2 inhalation.
Values of sR aw were minimized by 9% CO 2 inhalation in the fluoxetineperfused group (n ϭ 3) and the fluoxetine plus LY-53857-coperfused group (n ϭ 5). The minimum values of sR aw did not differ significantly between the two groups, as shown in Fig. 4A , inset. The relation between the percentage of the minimum value of sR aw (% of minimum sR aw ) and the inspired CO 2 fraction expressed as a percentage [FI CO 2 (%)] was significantly greater during 100% O 2 inhalation than during 9% CO 2 inhalation in each group (P Ͻ 0.05). During 100% O 2 inhalation, the % of minimum sR aw was also significantly greater in the fluoxetine plus LY-53857-coperfused group than Fig. 1 . Body temperature controlled with a heating lamp during fluoxetine perfusion or fluoxetine plus LY-53857 coperfusion with gas inhalation. E, fluoxetine-perfused group (n ϭ 3); F, fluoxetine plus LY-53857-coperfused group (n ϭ 5). N.S., not significant. FICO 2 (%), inspired CO2 fraction expressed as a percentage.
in the fluoxetine-perfused group (P Ͻ 0.05). The highest value of the % of minimum sR aw was observed in the period of 100% O 2 inhalation of the fluoxetine plus LY-53857-coperfused group, which was gradually decreased with increasing inspired-CO 2 concentration (Fig. 4A) .
Minute ventilation (V E ) during fluoxetine perfusion was significantly and dose-dependently increased from 13.2 Ϯ 1.1 ml/10 g body wt during 100% O 2 inhalation to 31.4 Ϯ 4.7 ml/10 g body wt at the end of the series of CO 2 inhalations (2.4-fold increase in the value during 100% O 2 inhalation, P Ͻ 0.05, n ϭ 3). V E during fluoxetine plus LY-53857 coperfusion increased from 8.7 Ϯ 0.4 ml/10 g body wt during 100% O 2 inhalation to 22.9 Ϯ 3.2 ml/10 g body wt at the end of the series of CO 2 inhalations (2.6-fold increase in the value during 100% O 2 inhalation, P Ͻ 0.05, n ϭ 5). The change in V E did not differ significantly between groups. However, the absolute values of V E at each CO 2 concentration in the fluoxetine plus LY-53857-coperfused group were significantly lower than those in the fluoxetine-perfused group (Fig. 4B , P Ͻ 0.05).
The respiratory rate (RR) in the fluoxetine-perfused group was significantly increased from 172 Ϯ 8/min at baseline to 239 Ϯ 4/min during 9% CO 2 inhalation (n ϭ 3, P Ͻ 0.05), and that in the fluoxetine plus LY-53857-coperfused group increased from 174 Ϯ 7/min at baseline to 228 Ϯ 8/min at the highest CO 2 concentration of the series (n ϭ 5). The increase in RR in the fluoxetine plus LY-53857-coperfused group did not differ significantly from that in the fluoxetine-perfused group (Fig. 5A) .
V T during fluoxetine perfusion was significantly and dose dependently increased from 0.076 Ϯ 0.004 ml/10 g body wt during 100% O 2 inhalation to 0.132 Ϯ 0.021 ml/10 g body wt at the end of the series of CO 2 inhalations (1.7-fold increase in the value during 100% O 2 inhalation, P Ͻ 0.05, n ϭ 3). V T during fluoxetine plus LY-53857 coperfusion increased from 0.051 Ϯ 0.004 ml/10 g body wt during 100% O 2 inhalation to 0.099 Ϯ 0.011 ml/10 g body wt at the end of the series of CO 2 inhalations (1.4-fold increase in the values during 100% O 2 inhalation, n ϭ 5). The change in V T did not differ significantly between groups. However, the absolute values of V T at each CO 2 concentration in the fluoxetine plus LY-53857-coperfused group were significantly lower than those in the fluoxetineperfused group (Fig. 5B) .
In response to step changes in inhaled CO 2 concentration, the relation between V T and T I was analyzed as a hyperbolic regression curve (Fig. 3C) (3) . The relation during fluoxetine plus LY-53857 coperfusion in the DMM shifted downward with unchanged slope compared with that during fluoxetine perfusion. The isopleths for V T /T I , as shown by the dotted lines, were lower during fluoxetine plus LY-53857 coperfusion than during fluoxetine perfusion.
DISCUSSION
In the present study, the effects of 5-HT release on 5-HT2 receptors in the DMM and CO 2 on ventilatory responses of airway resistance and respiratory variables were investigated in mice with microdialysis and double-chamber plethysmography. The sR aw during 5-HT2 receptor antagonism (LY-53857) plus an SSRI (fluoxetine) in the DMM was higher than that during SSRI perfusion alone. The increase in sR aw was largely reversed by CO 2 inhalation. Ventilatory volume during 5-HT2 receptor antagonism plus the SSRI in the DMM was lower than that during SSRI perfusion alone. Ventilatory volume was additively increased by CO 2 inhalation. However, the decrease in ventilatory volume induced by 5-HT2 receptor antagonism was not affected by CO 2 inhalation. These results suggest that 5-HT2 receptor activity in the DMM increases basal levels of airway dilation and ventilatory volume, that CO 2 inhalation increases airway dilation and ventilatory volume, that CO 2 inhalation under the condition of inhibited 5-HT2 receptor activity in the DMM facilitates ventilation due to compensatory airway dilation and additive augmentation of ventilatory volume, and that interaction between 5-HT2 receptor activity in the DMM and CO 2 drive may cause a cycle of hyperventilation with airway dilation and hypoventilation with airway narrowing.
Local anesthesia in addition to general anesthesia (preemptive analgesia) decreases postoperative pain. Peripheral neural blockade prevents nociceptive impulses from entering the central nervous system (6, 44) . Analgesics are likely to affect central function (4, 25, 49) . In the present study, 2% xylocaine was injected locally after induction of general anesthesia with pentobarbital sodium to affect preemptive analgesia.
Somatic nociceptive afferents represent effective stimuli for increases in RR (5). By double-chamber plethysmography, the RR of mice after surgery in the present study was similar to that of mice without any surgery in a previous study (15) . Resting values for RR, V T , and V E in mice in the present study were comparable with those of nonrestrained mice in a single chamber (16) .
A previous study showed that C57BL/6 mice exposed to 5% CO 2 in O 2 for 10 min show decreased pH from 7.4 to 7.3 and increased arterial partial pressure of CO 2 (Pa CO 2 ) from 43 mmHg to 56 mmHg (16) . Mice in the present study were exposed to step changes in inhaled CO 2 concentration (5%, 7%, and 9% CO 2 in O 2 ) at 8-min intervals and were likely hypercapnic and experiencing respiratory acidosis. The RR response to CO 2 inhalation was not significantly different between the fluoxetine perfusion and the fluoxetine plus LY-53857 coperfusion groups. Therefore, the arterial blood acidbase status was likely similar between the groups.
In the present study, 5-HT2 receptor activity in the DMM decreased airway resistance. 5-HT2 receptor activity in the nXII induces genioglossus muscle activity (7, 19) , which causes airway dilation. In the present study, hypercapnia also decreased airway resistance. Hypercapnia also elicits genioglossal muscle activity (31) . We found that airway narrowing induced by 5-HT2 receptor antagonism in the DMM was largely reversed by hypercapnia. Thus, hypercapnia-induced airway dilation was not mediated via 5-HT2 receptors in the DMM. There are reports questioning the role of 5-HT in the increase of genioglossus muscle activity in response to hypercapnia in rats (39, 40) . The facts suggest that hypercapnia and 5-HT2 receptor activity in the DMM compensate each other for airway dilation through distinct pathways.
5-HT2 receptor activity in the DMM increased the basal level of V E , dependent on tidal volume change, but did not affect the V E CO 2 response gain [⌬V E /⌬FI CO 2 (%)], although both V E and serotonergic neuron activity in the caudal raphe, which serves as a source of 5-HT in the DMM, increase as each function of inspired CO 2 (45) . Our results suggest that 5-HT release acting on 5-HT2 receptors in the nXII and nTS, rather than dose-dependent CO 2 responses, mediates increased basal levels of airway dilation and V E .
sR aw and V E responses were affected by four different conditions elicited by interaction between 5-HT2 receptor activity in the DMM and CO 2 drive (Fig. 4) . Condition 1 (arrow 1) was without 5-HT2 receptor activity in the DMM and with gradual increase in CO 2 drive. sR aw decreased, and V E increased. Condition 2 was with increased 5-HT2 receptor activity in the DMM and increased CO 2 drive. sR aw decreased to the minimum level, and V E increased to the maximum level. Condition 3 was with 5-HT2 receptor activity in the DMM and gradual decrease in CO 2 drive. sR aw increased slightly, and V E decreased. Condition 4 was decreased with 5-HT2 receptor activity in the DMM and decreased CO 2 drive. sR aw increased to the maximum level, and V E decreased to the minimum level. 5-HT in the nXII increases sleeping genioglossus muscle activity to normal waking levels (19) , and serotonergic caudal raphe neurons, which serve as a source of 5-HT in the DMM, are associated with locomotion, hypercapnia, and feeding, in addition to sleep-awake states (45) . Therefore, condition 1 is interpreted as representing the sleep state, without specific motor activity, condition 3 is interpreted as representing the arousal state, with the specific motor activity, and conditions 2 and 4 are interpreted as representing the transitional state between sleep and arousal or between on and off states of specific motor activity.
With respect to the inspiratory off-switch mechanism of the respiratory central pattern generator, CO 2 inputs have no systemic effect on volume threshold curves (1, 48) . In Fig. 5C , the V T /T I relation was shifted downward by 5-HT2 receptor antagonism in the DMM. The isopleths for V T /T I (dotted lines), which indicate central inspiratory activity, were decreased by 5-HT2 receptor antagonism (arrows). However, with the same chemical drive, inspiration was terminated at a lower volume threshold. These results suggest that 5-HT acting on 5-HT2 receptors in the DMM increases both central inspiratory activity and the volume threshold in the inspiratory off-switch mechanism. Neurons from the ventrolateral nTS project bilaterally to the phrenic nucleus (36) . Thus, 5-HT acting on 5-HT2 receptors in the DMM influences the inspiratory off-switch mechanism of the respiratory central pattern generator in the nTS and increases ventilatory volume.
With respect to the roles of the brain 5-HT system, there are two major hypotheses. Jacobs and Fornal (17) hypothesized that the serotonergic system in the brain facilitates activity of motor and premotor neurons. Richerson (35) hypothesized that 5-HT neurons in the medulla oblongata sense of CO 2 level and pH. Neurons in the nTS also act as central CO 2 chemoreceptors Fig. 4 . Effects of CO2 inhalation on specific airway resistance and ventilatory volume during fluoxetine perfusion or fluoxetine plus LY-53857 coperfusion in the DMM. A: percentages of the minimum specific airway resistance (sRaw) (% of minimum sRaw) in response to CO2 inhalation. Inset: sRaw during 9% CO2 inhalation with fluoxetine perfusion or fluoxetine plus LY-53857 coperfusion in the DMM. B: minute ventilation (V E) in response to CO2 inhalation values are means Ϯ SE. FICO 2 (%), inspired CO2 fraction expressed as a percentage; E, fluoxetine-perfused group (n ϭ 3); F, fluoxetine plus LY-53857-coperfused group (n ϭ 5). *P Ͻ 0.05 between data points or compared with increasing CO2 change; †P Ͻ 0.05 compared with 100% O2 in fluoxetine-perfused group. The contributions of 5-HT2 receptor activity in the DMM and hypercapnia to sRaw and ventilatory volume are denoted by arrows and numbers. (28) . In the present study, 5-HT2 receptor activity in the DMM increased basal levels of airway dilation and ventilatory volume, which was dependent on increased central inspiratory activity and volume threshold of the inspiratory off-switch mechanism. Hypercapnic responses of airway dilation and ventilatory augmentation were not suppressed by 5-HT2 receptor antagonism in the DMM. These results suggest that 5-HT release acting on 5-HT2 receptors in the DMM contributes to facilitation of respiratory motor and premotor neuron activity rather than to facilitation of sensitivity to CO 2 and pH.
5-HT afferents to the nXII originate from the raphe pallidus and obscurus nuclei (26) , and those to the nTS are derived from the raphe magnus, raphe pallidus, raphe obscurus, and dorsal raphe nuclei (37, 43) and from the nodose ganglia (29) . 5-HT concentration in the dorsal vagal complex, including the nTS, is increased by electrical stimulation of the raphe obscurus nucleus (2) . c-Fos expression induced by CO 2 is observed in serotonergic cells in the raphe pallidus nucleus (B1 group), its lateral extension (parapyramidal serotonergic cells), the raphe obscurus nucleus (B2 group), the raphe magnus nucleus (B3 group), and the dorsal raphe nucleus (B7 group) (13) . In the present study, CO 2 inhalation may have stimulated caudal raphe neurons and increased 5-HT release in the DMM. Further studies are necessary to determine the relation between 5-HT receptors and neuronal activity in the DMM.
In this study, the nXII, the dorsal motor nucleus of the vagus, and the nTS were included in the DMM, into which microdialysis probes were inserted. The mouse DMM extends ϳ1 mm 3 to each side. The microdialysis probe membrane, with a diameter of 0.24 mm and a length of 1 mm, was inserted near the center of the left DMM. Lesions produced by the microdialysis probes were located in the left DMM and included the nTS and the nXII. Fluorescent tracer perfused through a microdialysis probe on one side was reported to be centered largely within the nXII on both sides, due to extensive bilateral distribution of the dendrites of adult hypoglossal motoneurons in rats (27) . In the present study, fluoxetine and LY-53857 perfused through the same kind of microdialysis probe may have spread to the nXII on both sides.
In vagotomized rats, hypoglossal nerve activity is reduced by 35% to 81% by serotonergic and/or noradrenergic antagonists applied to the nXII (8) . Airway resistance is modified by many airway muscles, such as the tensor and levator velipalatine muscles, pharyngeal constrictors, and others (22) . It is possible that the hypercapnia-induced decrease in airway resistance may involve noradrenergic receptors in the nXII and other airway dilator muscles in addition to serotonergic receptors in the nXII and the genioglossus muscle.
Serotonergic receptors in the brain are up-regulated or sensitized in patients with OSA (14) . Eucapnic patients show an augmentation of postapneic ventilation (9) . In dogs, following release of occlusion, transient hyperventilation with an increase in inspiratory V E and a decrease in end-tidal CO 2 are accompanied by increases in V T (50) . Passive collapsibility and flow demand, depending on supine position and body mass index, determine the severity of OSA (51) . In OSA patients, arousal during sleep accompanied by airway reopening promotes ventilatory instability and likely exacerbates OSA (52) . We speculate that in OSA patients, hypercapnia during sleep and enhanced 5-HT2 receptor activity in the DMM during brief arousal cause greater airway dilation and hyperventilation. Subsequent hypocapnia and decreased 5-HT2 activity in the DMM during the return to sleep elicit airway narrowing and hypoventilation. Enhanced periodic breathing may be an exacerbating factor in periodic OSA.
In conclusion, 5-HT2 receptor activity in the DMM increases the basal levels of airway dilation and V T in mice, due to increases in central inspiratory activity and the volume threshold of the inspiratory off-switch mechanism, resulting in a facilitation of ventilation. Even though the effects of 5-HT2 receptor activity in the DMM on the airway and ventilatory volume are low, hypercapnia facilitates ventilation due to compensatory airway dilation and additive ventilatory volume augmentation. Interaction between 5-HT2 receptor activity in the DMM and CO 2 drive may elicit a cycle of hyperventilation with airway dilation and hypoventilation with airway narrowing, which may be a physiological mechanism to optimize ventilation in sleep-awake states or in states of special motor activity and may underlie the pathogenesis of periodic breathing and periodic OSA.
